Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000169110 | SCV000220310 | likely pathogenic | Hereditary fructosuria | 2014-05-12 | criteria provided, single submitter | literature only | |
Eurofins Ntd Llc |
RCV000723842 | SCV000231461 | pathogenic | not provided | 2014-06-13 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000169110 | SCV001361106 | pathogenic | Hereditary fructosuria | 2019-09-09 | criteria provided, single submitter | clinical testing | Variant summary: ALDOB c.612T>A (p.Tyr204X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 251356 control chromosomes (gnomAD). c.612T>A has been reported in the literature in multiple individuals affected with Hereditary Fructose Intolerance (e.g. Ali_1993, Esposito_2010). These data indicate that the variant is very likely to be associated with disease. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. |
Invitae | RCV000169110 | SCV001405976 | pathogenic | Hereditary fructosuria | 2023-01-13 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 188782). This variant is also known as Y203X. This premature translational stop signal has been observed in individual(s) with hereditary fructose intolerance (PMID: 8438046). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr204*) in the ALDOB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALDOB are known to be pathogenic (PMID: 18541450). |
Baylor Genetics | RCV000169110 | SCV004196604 | pathogenic | Hereditary fructosuria | 2023-09-10 | criteria provided, single submitter | clinical testing | |
ATS em Genética Clínica, |
RCV000169110 | SCV001573844 | likely pathogenic | Hereditary fructosuria | 2021-03-18 | no assertion criteria provided | literature only | |
Natera, |
RCV000169110 | SCV002078716 | pathogenic | Hereditary fructosuria | 2021-01-13 | no assertion criteria provided | clinical testing |